telomirpharma.com - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi TELO
The expansion of the small molecule pipeline for telomere control at Telomir Pharmaceuticals (TELO) stimulates strict oversight of chemical formula delivery to laboratories. Aggregate EBITDA clearly confirms this correlation, where 0.00 shows the value of this parameter. The result is the creation of a comprehensive longevity ecosystem that radically transforms methods for treating age-related pathologies and bodily recovery.
Telomir Pharmaceuticals, Inc. - rincian analitis lan metrik utama (TELO)
- nilai pasar lan prakiraan target analis:
- rincian nilai pasar emiten:
- statistik nilai buku emiten:
- rincian struktur utang lan likuiditas bisnis:
Rasio Kabeh Utang marang Dana Pribadi Telomir Pharmaceuticals|TELO - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal Telomir Pharma|TELO - Gunggung utang perusahaan|Utang-utang marang nilai buku Telomir Pharmaceuticals Inc|TELO - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Telomir Pharmaceuticals|Likuiditas darurat telomirpharma.com
- statistik bathi lan rasio pasar:
TELO - Bathi resik perusahaan|Bathi mangsa ngarep Telomir Pharmaceuticals|TELO - Pangali P/E|Kapitalisasi marang proyeksi bathi Telomir Pharmaceuticals Inc|TELO - Rasio rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Telomir Pharma|TELO - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku Telomir Pharmaceuticals|TELO - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan telomirpharma.com|TELO - Wutah bathi ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Telomir Pharmaceuticals
- indikator pendapatan dodolan lan penghasilan bisnis:
Ringkesan analitik perusahaan:Telomir Pharmaceuticals
This indicator is calculated as the difference between daily revenue from core operations and direct operating expenses, allowing for an assessment of the business's real liquidity excluding debt obligations. An analysis of operating cash flow before interest and taxes confirms the effectiveness of the outsourcing strategy at Telomir Pharmaceuticals (TELO), minimizing capital expenditures on laboratories and reducing the risk of capital drawdown during the scaling of research.
Pesaing Telomir Pharmaceuticals (TELO)
Bathi perusahaan sadurunge pajak, bunga, lan amortisasi HLN (Haleon plc)|KVUE: Bathi operasional sadurunge ngurangi amortisasi|Verona Pharma - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|MENS: Bathi operasional EBITDA|Ligand Pharma - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|AMRX (Amneal Pharmaceuticals, Inc.) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi perrigo.com PRGO|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Alvotech SA (ALVO)|LQDA (Liquidia Corp) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA GLPG (Galapagos N.V.)|Bathi operasional EBITDA ANI Pharmaceuticals Corp ANIP|Afrezza - Bathi operasional EBITDA|amphastar.com (AMPH) - Bathi operasional sadurunge ngurangi amortisasi|PCRX: Bathi operasional EBITDA|SPRY - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Theravance|Bathi sadurunge bunga, pajak, lan amortisasi Aquestive Corp AQST|Bathi operasional EBITDA SCPH|TECX - Bathi sadurunge bunga, pajak, lan amortisasi|Tonix Pharmaceuticals Holding Corp. - Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi SXTC|Eupraxia Pharmaceuticals, Inc. - Bathi operasional EBITDA|BHST: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|invizyne.com (EXOZ) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi ORMP (Oramed)|ENTX (Entera Bio) - Bathi operasional EBITDA|HYFT: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA ABVC|Cumberland Pharmaceuticals - Bathi operasional sadurunge amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Quantum BioPharma Ltd. QNTM|FGEN: Bathi operasional sadurunge amortisasi|Rani Therapeutics Inc - Bathi operasional EBITDA|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi SNYR (synergychc.com)|Rallybio (RLYB) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi Lexaria Bioscience Corp|Bathi operasional sadurunge ngurangi amortisasi PULM|PTHL - Bathi operasional sadurunge potongan amortisasi|Bathi operasional EBITDA APM|Pendapatan operasional sadurunge ngurangi amortisasi Lyra Therapeutics|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Impact BioMedical Inc IBO|TNFA - Bathi operasional sadurunge ngurangi amortisasi|cbdMD, Inc. - Bathi operasional EBITDA|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi PRFX (PainReform Ltd.)|CYTO (altamiratherapeutics.com) - Bathi operasional sadurunge ngurangi amortisasi|LIPO: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|OPTN (Optinose) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi Pieris (PIRS)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Procaps Group S.A. (PROC)|Bathi operasional EBITDA petrospharma.com (PTPI)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Qilian International Holding QLI|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi SLRN|TFF Pharmaceuticals, Inc. - Bathi operasional EBITDA
